Aladdin Healthcare Technologies SE
ALDNF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $174 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $22 | $2 | $0 | $0 |
| Gross Profit | -$22 | -$2 | $174 | $0 |
| % Margin | – | – | 100% | – |
| R&D Expenses | $230 | $548 | $0 | $0 |
| G&A Expenses | $328 | $856 | $537 | $0 |
| SG&A Expenses | $340 | $857 | $537 | $0 |
| Sales & Mktg Exp. | $12 | $1 | $0 | $0 |
| Other Operating Expenses | $11 | $0 | $0 | $0 |
| Operating Expenses | $1,041 | $1,793 | $1,909 | $26 |
| Operating Income | -$1,327 | -$1,715 | -$3,836 | -$26 |
| % Margin | – | – | -2,198.6% | – |
| Other Income/Exp. Net | -$396 | -$1,491 | -$1,143 | $0 |
| Pre-Tax Income | -$1,444 | -$3,319 | -$3,873 | -$26 |
| Tax Expense | -$207 | -$329 | $2,127 | $0 |
| Net Income | -$1,233 | -$2,990 | -$3,873 | -$26 |
| % Margin | – | – | -2,219.6% | – |
| EPS | -0.11 | -0.19 | -0.35 | -0.002 |
| % Growth | 42.1% | 45.7% | -15,809.1% | – |
| EPS Diluted | -0.11 | -0.19 | -0.35 | -0.002 |
| Weighted Avg Shares Out | 11,455 | 15,660 | 10,968 | 11,532 |
| Weighted Avg Shares Out Dil | 11,455 | 15,660 | 10,968 | 11,532 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $95 | $83 | $0 |
| Interest Expense | $116 | $72 | $20 | $0 |
| Depreciation & Amortization | $22 | $1,534 | $1 | $53 |
| EBITDA | -$1,306 | -$181 | -$1,708 | -$26 |
| % Margin | – | – | -979% | – |